NDC product
TABLET · Aesica Pharmaceuticals GmbH, Zwickau
NDC 16262-014 · Aesica Pharmaceuticals GmbH, Zwickau
Key facts
| Product NDC | 16262-014 |
|---|---|
| Nonproprietary name | Sodium Alendronate |
| Substances | ALENDRONIC ACID |
| Dosage form | TABLET |
| Labeler | Aesica Pharmaceuticals GmbH, Zwickau |
| Product type | DRUG FOR FURTHER PROCESSING |
| Marketing category | DRUG FOR FURTHER PROCESSING |
| Marketing start | Oct 19, 2015 |
| Marketing end | Nov 30, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory